Listened to the interview. A bit annoying on both sides. Interviewer has no idea what the results mean, just asking the same question two or three times. Vince's answer to the USA issues are not really satisfactory and he deflects.
So if the interviewer can't understand the results after three explanations, makes sense that regular investors went crazy over twitter-length snippets today
Likewise, there probably hasn't been enough time to actually investigate the issue. I mean, which clinic or supplier would say they messed up the first time they were asked? So just own up to that.
That being said, it looks glaringly obvious there has been a mix up. Should just say it: the manufacturer messed up the labeling or the data team messed up the ouput. We don't know which yet but we are looking into it.
Anyway, I'm doubling my position tomorrow as a data swap (which it f@cking is) isn't worth a 50% discount.
Ann: BTX 1503 Acne Phase 2 Study Results Presentation, page-244
-
- There are more pages in this discussion • 407 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
31.5¢ |
Change
-0.030(8.70%) |
Mkt cap ! $570.1M | |||
| Open | High | Low | Value | Volume |
| 34.5¢ | 34.5¢ | 31.5¢ | $6.354M | 19.19M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 286322 | 31.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.0¢ | 28500 | 1 |
View Market Depth
| Last trade - 16.10pm 01/07/2024 (20 minute delay) ? |
| BOT (ASX) Chart |